Docosahexaenoic Acid and Bronchopulmonary Dysplasia in Preterm Infants

Overview of attention for article published in New England Journal of Medicine, March 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

news: 8 news outlets
blogs: 2 blogs
twitter: 56 X users

facebook: 3 Facebook pages
googleplus: 1 Google+ user

Readers on

mendeley: 178 Mendeley

So far, Altmetric has seen 64 X posts from 56 X users, with an upper bound of 1,548,649 followers.

Two studies were eligible for inclusion - Collins et. al. 2017 and Marc et al. 2020 https://t.co/OzoV5LNA6a https://t.co/7kDqh5xgE3

DHA might reduce the risk of bronchopulmonary dysplasia in preterm infants, but appropriately designed trials are lacking. DHA supplementation did not result in a lower risk of physiological dysplasia compared to a control emulsion. https://t.co/Xsoi2ep…

Interestingly, original N3RO paper with primary outcome of BPD published in 2017 had shown a higher risk of BPD. Can we offset slightly higher short term risk with longer term benefit? https://t.co/lp5CAZ0hkI #neoEBM

RT @DrAbdulRazak_MD: @EBNEO @Nutrients_MDPI NEC rates pretty high in control population of 1-1.5 kg - might be due to low antenatal steroid…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 60 additional X posts.